Still’s Disease Treatment Market Companies

Still’s Disease Treatment Market, By Treatment, By Route of Administration, By Distribution Channels and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Aug 2023

Code : CMI4023

Pages :255

Formats :

Excel and PDF

Industry : Pharmaceutical

Leading Companies

Global Still’s Disease Treatment Market - Key Players

The major players operating in the global Still’s disease treatment market include AB2 Bio Ltd, F.Hoffmann-La Roche Ltd, Novartis AG, Swedish Orphan Biovitrum AB, Jubilant Life Sciences Ltd, Vintage Labs, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Mylan N.V, Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Amneal Pharmaceuticals LLC, Dr Reddy's Laboratories Ltd, and Fresenius Kabi AG.